Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy

SIMPLE SUMMARY: Glioma is a malignant primary brain tumor accounting for 75% of the total cases. Notably, several immunotherapeutic and chemotherapeutic agents in glioma have been demonstrated to induce immunogenic cell death (ICD). However, the studies on glioma have targeted individual ICD-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Zhiqiang, Jiang, Hongxiang, Yan, Tengfeng, Deng, Gang, Chen, Qianxue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688866/
https://www.ncbi.nlm.nih.gov/pubmed/36428756
http://dx.doi.org/10.3390/cancers14225665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688866/
https://www.ncbi.nlm.nih.gov/pubmed/36428756
http://dx.doi.org/10.3390/cancers14225665

Ejemplares similares